Danaher Schedules Third Quarter 2020 Earnings Conference Call

WASHINGTON, Oct. 7, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2020 on Thursday, October 22, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more

Bio-Techne Announces Opening of New Canadian Facility

MINNEAPOLIS, Oct. 1, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the opening of its new Canadian office located in Toronto. This new office will be the workplace for approximately 40 Bio-Techne employees and reflects the Company’s commitment to supporting the Canadian life sciences industry as well as expectations for continued growth in this geography. The... Read more

MTS Awarded Two Contracts Valued At $17 Million Collectively

EDEN PRAIRIE, Minn., Oct. 1, 2020 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC), a leading global supplier of advanced test systems, motion simulators and precision sensors, today announced two new awards for its test and simulation business totaling $17 million in contractual value. MTS will partner with a leading multi-national engineering and manufacturing conglomerate to provide... Read more

Phenomenex Announces Direct Sales and Support within the Czech Republic and Slovakia

Torrance, Calif. (10.1.2020) – Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, has announced that it will begin to directly serve customers in the Czech Republic and Slovakia, effective October, 01 2020. The new office will be operated out of Prague.  Phenomenex is a leading player... Read more

Bio-Techne Announces Grand Opening of GMP Manufacturing Facility

MINNEAPOLIS, Sept. 30, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the grand opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing Practices) manufacturing facility. Located in St. Paul, MN, the new facility is dedicated to supporting large-scale production of GMP-grade materials, including E. coli-derived recombinant proteins, which are an essential component for... Read more

PerkinElmer EONIS Screening Test Receives CE-IVD Clearance

RT-PCR Newborn Screening Assay for SMA, SCID and XLA to be Integrated into Company’s Sample-to-Result Workflow WALTHAM, Mass. – September 30, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the Company’s EONIS™ screening assay for newborns that simultaneously tests for SMA (spinal muscular atrophy), SCID (severe... Read more

Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2020 following the close of market on Thursday, October 29, 2020. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host... Read more

Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2

AUSTIN, Texas, Sept. 24, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received a $5,389,813 award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, to conduct product development work and complete... Read more

Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test

AUSTIN, Texas, Sept. 23, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received an award of $683,500 from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, to support the enhancement of... Read more

Bio-Techne Rebrands B-MoGen Biotechnologies as Part of the R&D Systems Product Portfolio

MINNEAPOLIS, Sept. 21, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that the B-MoGen Biotechnologies portfolio of genome engineering services, GMP therapeutic manufacturing services, and its proprietary transposon-transposase gene transfer system, TcBuster™, will be rebranded as R&D Systems. As part of the rebranding, the B-MoGen Biotechnologies website will be retired. Service details and purchasing... Read more